Avenue Therapeutics, Inc. Common Stock
ATXI
ATXI was delisted on the 18th of March, 2025.
31 hedge funds and large institutions have $29.7M invested in Avenue Therapeutics, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 7 closing their positions.
14% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 7
6% more capital invested
Capital invested by funds: $28.1M → $29.7M (+$1.58M)
9% less funds holding
Funds holding: 34 → 31 (-3)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.33M |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$535K |
| 3 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
+$474K |
| 4 |
BlackRock
New York
|
+$255K |
| 5 |
MAM
Martingale Asset Management
Boston,
Massachusetts
|
+$219K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$649K |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$547K |
| 3 |
Renaissance Technologies
New York
|
-$510K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$363K |
| 5 |
MSL
Mackay Shields LLC
New York
|
-$272K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Royal Bank of Canada
Toronto,
Ontario, Canada
| $23K | – | – | – |
|
27
Bank of America
Charlotte,
North Carolina
| $19K | – | – | – |
|
|
SO
28
STRS Ohio
Columbus,
Ohio
| $18K | – | – | – |
|
29
BNP Paribas Financial Markets
Paris,
France
| $14.8K | +$12.2K | +1 | New |
|
30
Legal & General Group
London,
United Kingdom
| $9K | – | – | – |
|
|
AIP
31
Ameritas Investment Partners
Lincoln,
Nebraska
| $6K | – | – | – |
|
32
Citigroup
New York
| $3K | -$12.2K | -1 | Closed |
|
33
Bank of Montreal
Toronto,
Ontario, Canada
| $3K | – | – | – |
|
|
KCM
34
Kennedy Capital Management
St Louis,
Missouri
| – | -$649K | -54 | Closed |
|
|
35
Osaic Holdings
Scottsdale,
Arizona
| – | -$363K | -30 | Closed |
|
|
MSL
36
Mackay Shields LLC
New York
| – | -$272K | -22 | Closed |
|
37
Squarepoint
New York
| – | -$236K | -19 | Closed |
|
38
Jane Street
New York
| – | -$151K | -12 | Closed |
|
|
HIM
39
Hillsdale Investment Management
Toronto,
Ontario, Canada
| – | -$23K | -2 | Closed |
|
ATXI Hedge Fund Activity: Q3 2020 in Review
31 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Avenue Therapeutics, Inc. Common Stock (ATXI) for Q3 2020, worth a combined $29.7M — up 5.6% from $28.1M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of ATXI and 4 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 8 added.
The largest buyer was Vanguard Group, adding an estimated $2.33M. The largest seller was Kennedy Capital Management, exiting entirely with an estimated $649K sold.
- 31 institutional investors held Avenue Therapeutics, Inc. Common Stock (ATXI) as of Q3 2020, down from 34 in Q2 2020.
- Funds reported $29.7M of Avenue Therapeutics, Inc. Common Stock stock for Q3 2020, up 5.6% quarter-over-quarter.
- 4 funds opened new Avenue Therapeutics, Inc. Common Stock positions in Q3 2020 and 7 closed out, a net change of -3 holders.
- The largest Avenue Therapeutics, Inc. Common Stock buyer in Q3 2020 was Vanguard Group, an estimated $2.33M added.
- The largest Avenue Therapeutics, Inc. Common Stock seller in Q3 2020 was Kennedy Capital Management, an estimated $649K sold.
Based on aggregated 13F filings for Q3 2020.